BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35751380)

  • 41. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
    Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
    Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy.
    Tian YM; Huang WZ; Yuan X; Bai L; Zhao C; Han F
    Oncotarget; 2017 Jun; 8(26):43450-43457. PubMed ID: 28427216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
    Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
    Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.
    Jin YN; Zhang WJ; Cai XY; Li MS; Lawrence WR; Wang SY; Mai DM; Du YY; Luo DH; Mo HY
    Cancer Res Treat; 2019 Jan; 51(1):34-42. PubMed ID: 29409313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.
    Tang LL; Chen L; Mao YP; Li WF; Sun Y; Liu LZ; Lin AH; Mai HQ; Shao JY; Li L; Ma J
    Radiother Oncol; 2015 Aug; 116(2):167-73. PubMed ID: 26316395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
    Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
    J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation-induced cancer after treatment for nasopharyngeal carcinoma: a study from a high prevalence area.
    Cao X; Wang C; Lin ZC; Lyu X
    Rhinology; 2023 Feb; 61(1):77-84. PubMed ID: 36527736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors influencing the incidence of sinusitis in nasopharyngeal carcinoma patients after intensity-modulated radiation therapy.
    Su YX; Liu LP; Li L; Li X; Cao XJ; Dong W; Yang XH; Xu J; Yu S; Hao JF
    Eur Arch Otorhinolaryngol; 2014 Dec; 271(12):3195-201. PubMed ID: 24659365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Xiao XT; Wu YS; Chen YP; Liu X; Guo R; Tang LL; Ma J; Li WF
    Cancer Med; 2023 Jan; 12(2):1399-1408. PubMed ID: 35822664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy.
    Laskar S; Bahl G; Muckaden M; Pai SK; Gupta T; Banavali S; Arora B; Sharma D; Kurkure PA; Ramadwar M; Viswanathan S; Rangarajan V; Qureshi S; Deshpande DD; Shrivastava SK; Dinshaw KA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):728-36. PubMed ID: 18374512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era.
    Kong L; Wang L; Shen C; Hu C; Wang L; Lu JJ
    Sci Rep; 2016 Sep; 6():32883. PubMed ID: 27616024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
    Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of intensity-modulated radiation therapy alone vs. intensity-modulated radiation therapy combined with chemotherapy in elderly nasopharyngeal carcinoma patients (aged >65 years).
    Mi JL; Meng YL; Wu HL; Cao YL; Zhang B; Pan YF; Zhou YY; Fan JF; Liao SF; Qin XL; Yao DC; Jiang W
    Strahlenther Onkol; 2020 Mar; 196(3):270-279. PubMed ID: 31748837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.
    Moretto F; Rampino M; Munoz F; Ruo Redda MG; Reali A; Balcet V; Badellino S; Piva C; Schena M; Airoldi M; Ostellino O; Pecorari G; Ragona R; Ricardi U
    Radiol Med; 2014 Aug; 119(8):634-41. PubMed ID: 24424659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer.
    Goto Y; Nakamura A; Ashida R; Sakanaka K; Itasaka S; Shibuya K; Matsumoto S; Kanai M; Isoda H; Masui T; Kodama Y; Takaori K; Hiraoka M; Mizowaki T
    Radiat Oncol; 2018 Jun; 13(1):118. PubMed ID: 29940984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial.
    Tian YM; Zhao C; Guo Y; Huang Y; Huang SM; Deng XW; Lin CG; Lu TX; Han F
    Cancer; 2014 Nov; 120(22):3502-9. PubMed ID: 25056602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superiority of intensity-modulated radiotherapy over three-dimensional conformal radiotherapy combined with brachytherapy in nasopharyngeal carcinoma: a planning study.
    Taheri-Kadkhoda Z; Pettersson N; Björk-Eriksson T; Johansson KA
    Br J Radiol; 2008 May; 81(965):397-405. PubMed ID: 18250121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Lyu Y; Ni M; Zhai R; Kong F; Du C; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2549-2557. PubMed ID: 33021689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.